...made by Massachusetts-based Abiomed Inc., weighs less than two pounds. It is intended for patients with end-stage heart failure who have more than a 70 percent chance of dying within a month.

...leave the hospital. During the clinical trial phase under way, the only patients who qualify are those with end-stage heart failure, who are too ill to qualify for a heart transplant and who have a less than 30 percent chance of surviving longer...

...heart, the device is a new type of left-ventricular assist device, intended as a long-term solution to end-stage heart failure. The surgery in England is born of the revolutionary idea that devices with more complicated cardiac tasks than...

...heart surgery, but less than the cost of heart transplant surgery. An estimated 100,000 Americans suffer from end-stage heart failure each year, but only about 2,000 human hearts are available for transplants. "The medical system desperately...

...transplantation at the Texas Heart Institute at St. Luke's Episcopal Hospital. The heart is intended for patients with end-stage heart failure who have more than a 70 percent chance of dying within a month. Before the surgery, the man "couldn't even...